Skip to main content
. 2019 Feb 19;9:2256. doi: 10.1038/s41598-019-38678-5

Figure 4.

Figure 4

Extrahepatic effects of Y27pPBHSA in cirrhotic rats. Cardiac rock2 and pdgfrb mRNA expression in Y27pPBHSA-treated cirrhotic rats. (A) Western blots for p-moesin/moesin, p-MLC/MLC and GAPDH in the heart from cirrhotic rats treated for 3–24 h with Y27pPBHSA. (B) rock2 and pdgfrb mRNA expression in femoral muscle of Y27pPBHSA-treated cirrhotic rats (C). Western blots for p-moesin/moesin, p-MLC/MLC and GAPDH in femoral muscle from cirrhotic rats treated for 3–24 h with Y27pPBHSA. (D) rock2 and pdgfrb mRNA expression in mesenteric artery of Y27pPBHSA-treated cirrhotic rats. (E) Western blots for p-moesin/moesin and GAPDH in mesenteric artery from cirrhotic rats treated for 3–24 h with Y27pPBHSA. (F) Results are expressed as mean ± standard error of the mean (SEM); n = 6/group. Abbreviations: p-MLC, phospho-myosin light chain; BDL, bile duct ligation.